Mathematical model of tumor volume dynamics in mice treated with electrochemotherapy
暂无分享,去创建一个
[1] D. Miklavčič,et al. Intrinsic Sensitivity of Tumor Cells to Bleomycin as an Indicator of Tumor Response to Electrochemotherapy , 1998, Japanese journal of cancer research : Gann.
[2] D. Mould,et al. Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations , 2015, CPT: pharmacometrics & systems pharmacology.
[3] D Miklavcic,et al. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.
[4] D. Miklavčič,et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer , 2015, Cancer Immunology, Immunotherapy.
[5] Damijan Miklavcic,et al. Modeling of electric field distribution in tissues during electroporation , 2013, Biomedical engineering online.
[6] D Miklavcic,et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma , 2008, British Journal of Cancer.
[7] Todd Jenkins,et al. Modeling of Non-Small Cell Lung Cancer Volume Changes during CT-Based Image Guided Radiotherapy: Patterns Observed and Clinical Implications , 2013, Comput. Math. Methods Medicine.
[8] Damijan Miklavcic,et al. The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals , 2005, IEEE Transactions on Biomedical Engineering.
[9] I. Tannock,et al. Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.
[10] Damijan Miklavcic,et al. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases , 2010, Expert review of anticancer therapy.
[11] G. De Nicolao,et al. A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development. , 2005, Basic & clinical pharmacology & toxicology.
[12] Damijan Miklavcic,et al. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors , 2012, Medical and Biological Engineering and Computing.
[13] D Miklavcic,et al. Electrochemotherapy in treatment of tumours. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[14] Muriel Golzio,et al. In Vivo Molecular Imaging and Histological Analysis of Changes Induced by Electric Pulses Used for Plasmid DNA Electrotransfer to the Skin: A Study in a Dorsal Window Chamber in Mice , 2012, The Journal of Membrane Biology.
[15] M. Čemažar,et al. Differential Mechanisms Associated with Vascular Disrupting Action of Electrochemotherapy: Intravital Microscopy on the Level of Single Normal and Tumor Blood Vessels , 2013, PloS one.
[16] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[17] D. Miklavčič,et al. Cell membrane electroporation- Part 1: The phenomenon , 2012, IEEE Electrical Insulation Magazine.
[18] L. Mir,et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.
[19] Damijan Miklavcic,et al. Intraoperative electrochemotherapy of colorectal liver metastases , 2014, Journal of surgical oncology.
[20] L. Mir,et al. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells , 2014, Oncoimmunology.
[21] L. Zitvogel,et al. Immunological aspects of cancer chemotherapy , 2008, Nature Reviews Immunology.
[22] D Miklavcic,et al. The importance of electric field distribution for effective in vivo electroporation of tissues. , 1998, Biophysical journal.
[23] P. Agostinis,et al. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy , 2014, Oncoimmunology.
[24] K. Swanson,et al. A mathematical model for brain tumor response to radiation therapy , 2009, Journal of mathematical biology.
[25] K. Flisar,et al. Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells , 2009 .
[26] E. Golden,et al. Radiotherapy and immunogenic cell death. , 2015, Seminars in radiation oncology.
[27] Damijan Miklavčič,et al. Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study , 2006 .
[28] Antje Walz,et al. Modeling of tumor growth and anticancer effects of combination therapy , 2009, Journal of Pharmacokinetics and Pharmacodynamics.
[29] F. Végran,et al. Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells , 2013, PloS one.
[30] L. Mir,et al. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice , 1997 .
[31] L. Mir,et al. Antitumor electrochemotherapy: New advances in the clinical protocol , 1996, Cancer.
[32] Antonio DeRosa,et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] Damijan Miklavčič,et al. Electrochemotherapy: from the drawing board into medical practice , 2014, BioMedical Engineering OnLine.
[34] G. Nicolao,et al. A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development , 2004 .
[35] Abhishek D. Garg,et al. Immunogenic cell death and DAMPs in cancer therapy , 2012, Nature Reviews Cancer.
[36] Laurence Zitvogel,et al. Immune parameters affecting the efficacy of chemotherapeutic regimens , 2011, Nature Reviews Clinical Oncology.